The Melanoma Research Alliance (MRA), the leading private funder of melanoma research, and the Saban Family Foundation, a charitable foundation focused on supporting medical, children’s and education programs in the United States and Israel, recently awarded $2.25 million in grants to three teams of investigators based at institutions in Israel and the United States. These awards will support research to improve the treatment of melanoma,…

Le Mieux Cosmetics recently presented its popular Eye Wrinkle Corrector to guests of Dine With Derek. Hosted by celebrity fashion stylist and newly-appointed Style Director of Bella NYC Magazine, Derek Warburton, the pre-Fashion Week event took place at New York City Meatpacking District hotspot Manon and included a fashion show, cocktails, and dinner for stylish guests.

For the launch of their new brand, Mio High Intensity Bodycare is engaging in a number of unique partnerships that marry fitness, wellness and beauty. 2014 partnerships to date include a series of beauty fitness events with website and media company Well+Good, started by spa industry journalists Melisse Gelula and Alexia Brue.

Co-Founder of iTAN Sun Spray Spa® Irina Kharsa recently helped select Miss California USA 2014 as one of the pageant’s eight judges. iTAN’s partnership with Miss California USA began in 2013 and, as part of the partnership, Miss California USA and Miss California Teen USA receive one year unlimited Sun Spray Spa services.

Suneva Medical, Inc. recently announced that it has amended its existing licensing agreement with Histogen, Inc. Under the terms of the amended agreement, Suneva Medical is the exclusive licensee for the distribution of the Regenica® skin care line through the physician-dispensed channel in Europe, most of Asia, South America, Canada, Australia, and the Middle East.

Spafinder Wellness 365 recently announced its 2014 Spa and Wellness Trends Forecast at a global webinar led by Susie Ellis, president, and Mia Kyricos, chief brand officer. The annual report is an in-depth forecast of the most significant global trends that will impact the industry and consumers in the year ahead.

The United States Food and Drug Administration (FDA) recently announced that it had granted a first-ever approval of a combination treatment for melanoma, the most deadly type of skin cancer. The agency approved the combination of GlaxoSmithKline’s genetically-targeted dabrafenib (Tafinlar™) and trametinib (Mekinist™) for patients with metastatic or unresectable melanoma whose tumors possess either the BRAF V600E or V600K genetic mutations.

Sente, Inc. recently announced that the company has entered into a strategic partnership with ZendyBeauty, the innovative online platform connecting patients with Board-Certified cosmetic dermatologists and plastic surgeons. Under this alliance, each new and existing doctor to join the ZendyBeauty network will receive Sente Dermal Repair Cream, the first and only skin care regimen to utilize low molecular weight heparan sulfate (HS).